Value of Gd-EOB-DTPA-enhanced MRI in diagnosis of hepatocellular carcinoma

Value of Gd-EOB-DTPA-enhanced MRI in diagnosis of hepatocellular carcinoma

Objective To investigate the value of Gd-EOB-DTPA-enhanced MRI in the diagnosis of hepatocellular carcinoma (HCC). Methods A total of 40 patients with liver cirrhosis or suspected HCC who visited General Hospital of Shenyang Military Area Command from October 2016 to April 2017 were enrolled, and th...

Full description

Bibliographic Details
Main Author:	SUN Yu
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2018-01-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	hepatocellular； diffusion magnetic resonance imaging； gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid carcinoma hepatocellular; diffusion magnetic resonance imaging; gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=8687

Similar Items

The Impact of Gd-Eob-Dtpa-Enhanced MR Cholangiography in Biliary Diseases: Comparison with T2-Weighted MR Cholangiopancreatography
by: Evrim Özmen, et al.
Published: (2016-06-01)

Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation
by: Feiqian Wang, et al.
Published: (2020-01-01)

Preliminary clinical study of the safety of hepatectomy predicted by gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced T1 mapping magnetic resonance imaging
by: Jiao Liu, et al.
Published: (2021-03-01)

Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI
by: Yun-Jin Jang, et al.
Published: (2013-11-01)

OATP1B3 Expression in Hepatocellular Carcinoma Correlates with Intralesional Gd-EOB-DTPA Uptake and Signal Intensity on Gd-EOB-DTPA-Enhanced MRI
by: Zhou X, et al.
Published: (2021-02-01)

Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma
by: Tomoko Aoki, et al.
Published: (2021-08-01)

Feasibility and efficacy study of microwave ablation of recurrent small HCC guided by enhanced liver-specific magnetic resonance imaging contrast agent
by: Zheng-Yu Lin, et al.
Published: (2020-01-01)

A Case of a Desmoid Tumor with an Ureterotumoral Fistula Detected on Renal Scintigraphy
by: Hyun Woo Yoo, et al.
Published: (2016-11-01)

99m Tc dtpa renogram indentifies bochdalek hernia with an intra thoracic kidney as its content
by: Subramanyam Padma, et al.
Published: (2014-01-01)

Feasibility of Quadruple Arterial Phase of Motion Insensitive Radial Volumetric Imaging Breath-Hold Examination with k-Space Weighted Image Contrast in the Detection of Hepatocellular Carcinoma in Patients with Chronic Liver Disease
by: Min Ah Lee, et al.
Published: (2018-10-01)

Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma
by: Hanyu Jiang, et al.
Published: (2019-12-01)

Novel Strategy for Diagnosis of Focal Nodular Hyperplasia Using Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid: Enhanced Magnetic Resonance Imaging and Magnetic Resonance Elastography
by: Nobutaka Takeda, et al.
Published: (2021-06-01)

Lung clearance of 99mTc-DTPA in systemic lupus erythematosus
by: P.T.R. Dalcin, et al.
Published: (2002-06-01)

Human Whole Body Pharmacokinetic Minimal Model for the Liver Specific Contrast Agent Gd-EOB-DTPA
by: Forsgren, Mikael Fredrik
Published: (2011)

Fully automated convolutional neural network-based affine algorithm improves liver registration and lesion co-localization on hepatobiliary phase T1-weighted MR images
by: Kyle A. Hasenstab, et al.
Published: (2019-10-01)

Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma
by: Xue-Qin Li, et al.
Published: (2020-08-01)

A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging
by: Sun J, et al.
Published: (2019-12-01)

Prediction of Post-hepatectomy Liver Failure in Patients With Hepatocellular Carcinoma Based on Radiomics Using Gd-EOB-DTPA-Enhanced MRI: The Liver Failure Model
by: Yuyan Chen, et al.
Published: (2021-03-01)

Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
by: Maiwald, Bettina, et al.
Published: (2014)

An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation
by: Kovac Jelena Djokic, et al.
Published: (2021-01-01)

Early Detection of Local Tumor Progression after Irreversible Electroporation (IRE) of a Hepatocellular Carcinoma Using Gd-EOB-DTPA-Based MR Imaging at 3T
by: Wolf Bäumler, et al.
Published: (2021-03-01)

Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
by: So Yeon Kim
Published: (2020-07-01)

Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
by: T Mortezazadeh, et al.
Published: (2020-02-01)

Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
by: Jens Ricke, et al.
Published: (2020-12-01)

HCC screening: assessment of an abbreviated non-contrast MRI protocol
by: Michael Vinchill Chan, et al.
Published: (2019-12-01)

Recent Updates of Abbreviated MRI for Hepatocellular Carcinoma Screening
by: Jeong Woo Kim, et al.
Published: (2021-03-01)

Differentiation of Small Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Liver: Texture Analysis Based on MRI Improved Performance in Comparison Over Gadoxetic Acid-Enhanced MR and Diffusion-Weighted Imaging
by: Xi Zhong, et al.
Published: (2020-01-01)

HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI
by: Timo Alexander Auer, et al.
Published: (2021-02-01)

A Comprehensive Review of Hepatocellular Carcinoma Enhancement Patterns in MRI: Emphasis on Gadoxetate-Enhanced Imaging
by: Seung-seob Kim, et al.
Published: (2019-05-01)

Magnetic resonance-retrograde pyelography: A novel technique for evaluation of chyluria
by: Apul Goel, et al.
Published: (2014-01-01)

Differentiation of hepatocellular adenoma by subtype and hepatocellular carcinoma in non-cirrhotic liver by fractal analysis of perfusion MRI
by: Beaufrère, A., et al.
Published: (2022)

Diagnostic Performance of Simulated Abbreviated MRI for Early-Stage Hepatocellular Carcinoma Screening: A Comparison to Conventional Dynamic Contrast-Enhanced MRI
by: Eun Sol Lim, et al.
Published: (2021-09-01)

MRI Contrast Enhancement using Gd2O3 Nanoparticles
by: Klasson, Anna
Published: (2008)

Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging
by: G H Meftahi, et al.
Published: (2020-12-01)

MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018
by: Fang, Z., et al.
Published: (2022)

Recent advance of Gd-based contrast agents on <i>T</i><sub>1</sub>-weighted MRI
by: Wang Kaili, et al.
Published: (2018-02-01)

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
by: Sunyoung Lee, et al.
Published: (2020-07-01)

Value of Image Subtraction for the Identification of Hepatocellular Carcinoma Capsule on Gadoxetic Acid-Enhanced MRI
by: Hyunjung Kim, et al.
Published: (2018-12-01)

Toxicity associated with gadolinium-based contrast-enhanced examinations
by: Silvia Maria Lattanzio
Published: (2021-05-01)

Usefulness of subtraction pelvic magnetic resonance imaging for detection of ovarian endometriosis
by: Hyun Jung Lee
Published: (2020-04-01)